IL7R and acute lymphoblastic leukemia: Furthermore, the arginine to serine substitution at residue 98 (R98S) of RPL10, a mutation identified in up to 8% of patients with T-ALL, was shown to increase the expression of IL7R and downstream signaling molecules [60].